Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

The prevalence of PI*S and PI*Z SERPINA1 alleles in healthy individuals and COPD patients in Saudi Arabia: A case-control study.

Al-Jameil N, Hassan AA, Hassanato R, Isac SR, Otaiby MA, Al-Shareef F, Al-Maarik B, Ajeyan IA, Al-Bahloul K, Ghani S, Al-Torbak D.

Medicine (Baltimore). 2017 Oct;96(42):e8320. doi: 10.1097/MD.0000000000008320.

2.

Clinical heterogeneity and potential high pathogenicity of the Mmalton Alpha 1 antitrypsin allele at the homozygous, compound heterozygous and heterozygous states.

Joly P, Guillaud O, Hervieu V, Francina A, Mornex JF, Chapuis-Cellier C.

Orphanet J Rare Dis. 2015 Oct 7;10:130. doi: 10.1186/s13023-015-0350-6.

3.

How Can We Improve the Detection of Alpha1-Antitrypsin Deficiency?

Ferrarotti I, Poplawska-Wisniewska B, Trevisan MT, Koepke J, Dresel M, Koczulla R, Ottaviani S, Baldo R, Gorrini M, Sala G, Cavallon L, Welte T, Chorostowska-Wynimko J, Luisetti M, Janciauskiene S.

PLoS One. 2015 Aug 13;10(8):e0135316. doi: 10.1371/journal.pone.0135316. eCollection 2015.

4.

Unusually difficult clinical presentation of an infant suffering from congenital Cytomegalovirus (CMV) infection combined with alpha 1-antitrypsin (A1AT) deficiency.

Potočnjak I, Tešović G, Kuna AT, Stefanović M, Zaja O.

Biochem Med (Zagreb). 2014 Oct 15;24(3):396-402. doi: 10.11613/BM.2014.043. eCollection 2014.

5.

Alpha 1 antitrypsin deficiency in infants with neonatal cholestasis.

Monajemzadeh M, Shahsiah R, Vasei M, Tanzifi P, Rezaei N, Najafi M, Soleimanifar N, Eghbali M.

Iran J Pediatr. 2013 Oct;23(5):501-7.

6.

A novel SERPINA1 mutation causing serum alpha(1)-antitrypsin deficiency.

Saunders DN, Tindall EA, Shearer RF, Roberson J, Decker A, Wilson JA, Hayes VM.

PLoS One. 2012;7(12):e51762. doi: 10.1371/journal.pone.0051762. Epub 2012 Dec 12.

7.

Alpha-1 Antitrypsin Deficiency PI*Z and PI*S Gene Frequency Distribution Using on Maps of the World by an Inverse Distance Weighting (IDW) Multivariate Interpolation Method.

Blanco I, de Serres FJ, Cárcaba V, Lara B, Fernández-Bustillo E.

Hepat Mon. 2012 Oct;12(10 HCC):e7434. doi: 10.5812/hepatmon.7434. Epub 2012 Oct 21.

8.

Quantitative proteomic analyses of cerebrospinal fluid using iTRAQ in a primate model of iron deficiency anemia.

Patton SM, Coe CL, Lubach GR, Connor JR.

Dev Neurosci. 2012;34(4):354-65. doi: 10.1159/000341919. Epub 2012 Sep 26.

9.

The prevalence of alpha-1 antitrypsin deficiency in Ireland.

Carroll TP, O'Connor CA, Floyd O, McPartlin J, Kelleher DP, O'Brien G, Dimitrov BD, Morris VB, Taggart CC, McElvaney NG.

Respir Res. 2011 Jul 13;12:91. doi: 10.1186/1465-9921-12-91.

10.

Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha₁-antitrypsin deficiency: a randomized study.

Stocks JM, Brantly ML, Wang-Smith L, Campos MA, Chapman KR, Kueppers F, Sandhaus RA, Strange C, Turino G.

BMC Clin Pharmacol. 2010 Sep 30;10:13. doi: 10.1186/1472-6904-10-13.

11.

Accelerated spirometric decline in New York City firefighters with α₁-antitrypsin deficiency.

Banauch GI, Brantly M, Izbicki G, Hall C, Shanske A, Chavko R, Santhyadka G, Christodoulou V, Weiden MD, Prezant DJ.

Chest. 2010 Nov;138(5):1116-24. doi: 10.1378/chest.10-0187. Epub 2010 Jul 15.

12.

Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood.

Pott GB, Chan ED, Dinarello CA, Shapiro L.

J Leukoc Biol. 2009 May;85(5):886-95. doi: 10.1189/jlb.0208145. Epub 2009 Feb 5.

13.

Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk.

Yang P, Sun Z, Krowka MJ, Aubry MC, Bamlet WR, Wampfler JA, Thibodeau SN, Katzmann JA, Allen MS, Midthun DE, Marks RS, de Andrade M.

Arch Intern Med. 2008 May 26;168(10):1097-103. doi: 10.1001/archinte.168.10.1097.

Supplemental Content

Support Center